Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Manchin-Schumer Bill Gets Budget-Office Nod for $102 Billion Deficit Cut

Published 03/08/2022, 21:18
Updated 03/08/2022, 21:18
© Bloomberg. The US Capitol building in Washington, D.C., US, on Tuesday, June 21, 2022. The White House and congressional Democrats are in advanced talks on legislation that aims to fight inflation, rein in the deficit and revive parts of President Joe Biden's stalled economic agenda.

© Bloomberg. The US Capitol building in Washington, D.C., US, on Tuesday, June 21, 2022. The White House and congressional Democrats are in advanced talks on legislation that aims to fight inflation, rein in the deficit and revive parts of President Joe Biden's stalled economic agenda.

(Bloomberg) -- The Senate Democrats’ tax, climate and drug-price bill would reduce federal budget deficits by $102 billion over 10 years, the nonpartisan Congressional Budget Office said. 

In addition, the CBO calculated that increasing the Internal Revenue Service budget would generate $204 billion in new revenue from cracking down on tax avoidance, something that wasn’t included in the official deficit score. When that is factored in, the CBO analysis is in line with the $300 billion in deficit reduction claim initially made for the bill by Senate Majority Leader Chuck Schumer and West Virginia Senator Joe Manchin. 

The CBO estimate will be used both to sell the bill to the public and by the top Senate rules official to determine whether provisions comply with the chamber’s budget rules. Elements that don’t affect the budget could be stricken from the bill.

The deficit decrease is driven in part by a repeal of a Trump administration restriction on prescription drug rebates, generating $122 billion and by allowing Medicare to negotiate the cost of high-priced drugs, which generates $102 billion.

A 15% corporate minimum tax on large corporations generates $313 billion, as expected, while a narrowing of the carried interest loophole nets $13 billion in the score, slightly less than Democrats forecast.

The bill’s spending includes $31 billion to provide Obamacare premium subsidies for three years along with a slew of tax breaks for clean energy. 

Budget watchdogs on Wednesday urged Congress to resist pressure by business groups to gut the corporate tax and carried interest changes.

“The Inflation Reduction Act is the largest deficit-reduction bill in over a decade. But it’s only a first step toward fighting surging inflation and tackling our $24 trillion national debt. We can’t let special interests water it down,” said Maya MacGuineas of the Committee for a Responsible Federal Budget.

©2022 Bloomberg L.P.

© Bloomberg. The US Capitol building in Washington, D.C., US, on Tuesday, June 21, 2022. The White House and congressional Democrats are in advanced talks on legislation that aims to fight inflation, rein in the deficit and revive parts of President Joe Biden's stalled economic agenda.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.